We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

16 Nov 2026 - 19 Nov 2026
08 Dec 2026 - 10 Dec 2026

Scalp Cooling System Reduces Cancer Patients Hair Loss

By HospiMedica International staff writers
Posted on 02 Jul 2019
A fourth-generation medical cooling device offers cancer patients the ability to minimize alopecia (hair loss) during chemotherapy treatments.

The Dignitana (Lund, Sweden) DigniCap Delta scalp cooling system is indicated for the prevention of chemotherapy-induced hair loss in patients with solid tumors. More...
The system works by circulating liquid coolant through a flexible cooling wrap and an adjustable thermal cap that optimize scalp cooling outcomes. The cooling wrap is placed directly on the head to deliver consistent, controlled cooling to the scalp, while the outer thermal neoprene cap insulates and secures it tightly in place, with two built-in sensors continuously monitoring scalp temperature in order to maintain optimal cooling throughout.

Key system features include a quick-disconnect to accommodate bathroom breaks, an intuitive touch screen interface to simplify system operation, and flash memory that makes it possible to save data from each scalp cooling treatment and facilitates software upgrades. A built-in safety sensor ensures cooling temperature does not drop below freezing point. The cooling cap itself is available in multiple sizes to insure a personalized fit, and has a smooth inner surface to enable optimal contact between scalp and cap. Two independently controlled systems can be used for simultaneous treatment of two patients.

“DigniCap Delta changes everything about the way scalp cooling is done today. We are thrilled to offer patients and clinicians this state-of-the-art advancement in cancer care,” said William Cronin, CEO of Dignitana. “The clearance of Delta now provides a clear pathway for growth in the important US market and beyond. It is the biggest step yet in the evolution of Dignitana, and is the result of a tremendous effort from our staff, partner sites, regulatory team and contract manufacturer.”

As the temperature of the scalp is lowered, the subsequent blood vessel vasoconstriction reduces the amount of chemotherapy agents that reach it, as well as reducing uptake of drugs in the hair follicles due to decreased intra-follicular metabolic rate. The combined actions are thought to reduce the effect chemotherapy has on the cells, which may reduce hair loss.

Related Links:
Dignitana


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.